Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

   141,861,898      
Direct Value   $82,119,756    

Indirect Value

   $12,961,771,173      
Total Shares   142,789,105      
Total Value   $13,043,890,929      


Incyte Corp $32,589,847 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $312,474 Neurogene $16,634 Incyte Corp $32,589,847 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $312,474 Neurogene $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    36   
    6    

     Stock price went up :
    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 53 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SGEN Seagen Inc Director   –       •       •   2009-08-11 4 B $10.75 $2,939,093 I/I 273,404 4,626,213 2.25 -
INCY Incyte Corp Director   –       •       •   2022-02-11 4 B $66.81 $18,475,727 I/I 276,507 32,028,637 2.25 %
SGEN Seagen Inc Director   –       •       •   2006-05-24 4 B $5.25 $1,462,913 I/I 278,650 667,288 2.25 -
VPHM Viropharma Inc 10% Owner   –       –       •   2007-11-07 4 B $7.27 $2,030,532 I/I 279,134 4,231,181 1.5 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2007-06-19 4 S $5.64 $1,609,287 I/I (282,843) 2,274,247 0 -
INCY Incyte Corp Director   –       •       •   2008-12-19 4 B $3.60 $1,024,003 I/I 284,546 7,027,300 2.25 -
VPHM Viropharma Inc 10% Owner   –       –       •   2010-05-06 4 S $12.62 $3,625,407 I/I (286,764) 2,849,035 0 -
INCY Incyte Corp Director   –       •       •   2022-02-17 4 B $67.40 $19,844,805 I/I 292,972 32,824,461 2.25 %
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2008-05-07 4 A $0.00 $0 I/I 294,624 1,462,184 0 -
GHDX Genomic Health Inc Director   –       •       •   2011-03-07 4 B $24.90 $7,430,585 I/I 297,340 5,601,422 2.25 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2007-12-19 4 B $13.25 $3,949,030 I/I 298,040 1,078,767 1.5 -
INCY Incyte Corp Director   –       •       •   2008-01-04 4 B $9.47 $2,828,166 I/I 298,752 4,575,438 2.25 -
KOD Kodiak Sciences Inc. Director   –       •       •   2022-02-17 4 B $53.82 $16,367,881 I/I 300,000 14,734,965 2.25 %
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2008-11-20 4 B $1.00 $303,517 I/I 303,517 4,309,994 1.5 -
KOD Kodiak Sciences Inc. Director   –       •       •   2022-06-06 4 B $7.75 $2,361,093 I/I 303,917 15,967,504 2.25 %
SGEN Seagen Inc Director   –       •       •   2010-04-30 4 B $12.56 $3,870,283 I/I 306,022 10,552,695 2.25 -
INCY Incyte Corp Director   –       •       •   2010-08-09 4 S $14.08 $4,416,947 I/I (313,622) 8,616,083 0 -
SGEN Seagen Inc Director   –       •       •   2007-07-09 4 A $0.00 $0 I/I 316,500 320,498 0 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-05-22 4 B $5.64 $1,786,493 I/I 316,754 2,803,892 1.5 -
TPPHQ Tapestry Pharmaceuticals ... 10% Owner   –       –       •   2006-04-25 4 D $0.00 $0 I/I (319,355) 0 -
TPPHQ Tapestry Pharmaceuticals ... 10% Owner   –       –       •   2006-04-25 4 A $0.00 $0 I/I 319,355 1,844,485 -
INCY Incyte Corp Director   –       •       •   2012-01-12 4 B $16.21 $5,297,473 I/I 325,728 12,213,272 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2006-11-15 4 B $5.66 $1,856,016 I/I 328,092 4,080,034 1.5 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-06-27 4 S $15.41 $5,109,925 I/I (331,598) 601,511 0 -
INCY Incyte Corp Director   –       •       •   2011-12-06 4 B $13.52 $4,578,060 I/I 338,406 11,339,120 2.25 -
  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53  54   55   56      
  Page 53 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us